company background image
MCOV B logo

Medicover OM:MCOV B Stock Report

Last Price

SEK 173.20

Market Cap

SEK 26.0b

7D

-3.8%

1Y

17.4%

Updated

21 Nov, 2024

Data

Company Financials +

Medicover AB (publ)

OM:MCOV B Stock Report

Market Cap: SEK 26.0b

MCOV B Stock Overview

Provides healthcare and diagnostic services in Poland, Sweden, and internationally. More details

MCOV B fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance3/6
Financial Health1/6
Dividends0/6

Rewards

Trading at 50.4% below our estimate of its fair value

Earnings are forecast to grow 40.94% per year

Earnings grew by 146.3% over the past year

Analysts in good agreement that stock price will rise by 23.9%

Risk Analysis

Interest payments are not well covered by earnings

Significant insider selling over the past 3 months

Large one-off items impacting financial results


Medicover AB (publ) Competitors

Dedicare

OM:DEDI

SEK 564.2m

Elekta

OM:EKTA B

SEK 23.7b

Attendo

OM:ATT

SEK 7.5b

Ambea

OM:AMBEA

SEK 7.8b

Price History & Performance

Summary of all time highs, changes and price drops for Medicover
Historical stock prices
Current Share PriceSEK 173.20
52 Week HighSEK 206.50
52 Week LowSEK 129.20
Beta1.46
11 Month Change-6.07%
3 Month Change-6.68%
1 Year Change17.42%
33 Year Change-40.17%
5 Year Change65.58%
Change since IPO164.43%

Recent News & Updates

The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Nov 07
The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Oct 24
Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Recent updates

The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Nov 07
The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Oct 24
Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Apr 22
Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Apr 04
Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Mar 05
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Feb 11
Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Dec 20
Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Dec 02
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Sep 12
Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Aug 21
Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Jun 12
Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

May 27
Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

Is Medicover (STO:MCOV B) Using Too Much Debt?

May 12
Is Medicover (STO:MCOV B) Using Too Much Debt?

Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Feb 16
Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Is Medicover (STO:MCOV B) Using Too Much Debt?

Jan 30
Is Medicover (STO:MCOV B) Using Too Much Debt?

Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?

Dec 30
Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?

Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)

Dec 17
Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)

Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Oct 30
Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Oct 16
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?

Sep 09
Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?

Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)

Jul 25
Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Jul 12
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)

Jun 13
Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)

At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?

May 29
At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?

Shareholder Returns

MCOV BSE HealthcareSE Market
7D-3.8%-2.5%-2.1%
1Y17.4%29.9%10.8%

Return vs Industry: MCOV B underperformed the Swedish Healthcare industry which returned 29.9% over the past year.

Return vs Market: MCOV B exceeded the Swedish Market which returned 10.8% over the past year.

Price Volatility

Is MCOV B's price volatile compared to industry and market?
MCOV B volatility
MCOV B Average Weekly Movement3.7%
Healthcare Industry Average Movement4.0%
Market Average Movement5.6%
10% most volatile stocks in SE Market11.2%
10% least volatile stocks in SE Market3.3%

Stable Share Price: MCOV B has not had significant price volatility in the past 3 months compared to the Swedish market.

Volatility Over Time: MCOV B's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199545,000Fredrik Rågmarkwww.medicover.com

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company’s Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology.

Medicover AB (publ) Fundamentals Summary

How do Medicover's earnings and revenue compare to its market cap?
MCOV B fundamental statistics
Market capSEK 26.03b
Earnings (TTM)SEK 228.63m
Revenue (TTM)SEK 23.19b

113.7x

P/E Ratio

1.1x

P/S Ratio

Is MCOV B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MCOV B income statement (TTM)
Revenue€2.00b
Cost of Revenue€1.58b
Gross Profit€413.60m
Other Expenses€393.90m
Earnings€19.70m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 12, 2025

Earnings per share (EPS)0.13
Gross Margin20.70%
Net Profit Margin0.99%
Debt/Equity Ratio121.9%

How did MCOV B perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

91%

Payout Ratio